In this Issue
Notable Discoveries and Unsolved Mysteries of Glaucoma Treatment Targets
Chief Medical Editor’s Page
By Iqbal Ike K. Ahmed, MD, FRCSC
Evidence from randomized controlled trials supports the use of two less invasive glaucoma treatment options, selective laser trabeculoplasty and a microstent.
By Chelvin Sng, MBBChir, MA, MMed, FRCS(Ed); and Keith Barton, MD, FRCP, FRCS
Catch up on research comparing glaucoma surgical procedures, examining real-world diagnosis and treatment, and exploring the nature of the disease itself.
By Sarwat Salim, MD, FACS; and Albert S. Khouri, MD
Physicians explore whether another form of optic neuropathy caused this patient’s visual
By Douglas J. Rhee, MD; Thomas Patrianakos, MD; Shakeel Shareef, MD; and Arthur J. Sit, MD
Tips and tricks for performing this cost-effective glaucoma surgery.
By Zeynep Aktas, MD, FEBO
RESIDENTS & FELLOWS
Discovering the value of international outreach during glaucoma fellowship.
By Matthew Miller, MD
Enormous challenges exist, but pragmatic advances are being made.
By Dan Kiage, MD, MB ChB, MMed, FEACO
A better understanding of what governs the homeostasis of outflow is vital to understanding the early pathology of glaucoma.
By Ronald L. Fellman, MD; and Davinder S. Grover, MD, MPH
A look at emerging technologies targeting the suprachoroidal space.
By R. Allan Sharpe, MD; and Peter T. Chang, MD
A look at different approaches to managing postoperative fibrosis after glaucoma surgery.
By Ian Pitha, MD, PhD
A closer look at the mechanism of action for a familiar medication class.
By Jacob W. Brubaker, MD
Reviewing the mechanisms behind one of the newest classes of glaucoma drugs.
By Mehak Aziz, MD; and Rachel W. Kuchtey, MD, PhD
Building a cohesive team is essential for practice success.
By Vance Thompson, MD, FACS
A look at the Trump administration’s approach.